BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Hits Primary Endpoint

  The primary endpoint was objective response rate (ORR). Secondary objectives included duration of response, disease control rate, clinical benefit rate, progression-free survival and overall survival.

  May 8, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Sarepta Adds a Sixth LGMD Gene Therapy Candidate to its Arsenal

  Sarepta struck a deal with the Research Institute at Nationwide Children’s Hospital for the gene therapy candidate, calpain 3.

  May 8, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  BioSpace’s Global Biopharma Roundup: May 9

  Companies from across the globe provide updates to their pipelines and businesses, with news from BioNTech, Mologic, Akcea, RedHill, and more.

  May 8, 2019

   · 

  4 min read

   · 

  Alex Keown